Notícias · Recifes

Researchers discover treatable cause of severe anemia associated with a cancer therapy

Researchers at the Mount Sinai Tisch Cancer Center have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors, a widely used class of targeted cancer therapies. Their findings, published in the latest iss

Admin Recifes 15/07/2026 2

Brain tumor vaccine links mutation targeting to eight-year survival gains

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions

Admin Recifes 15/07/2026 2

New AI system provides treatment recommendations for complex blood cancers

Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed "HemaGuide," an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has

Admin Recifes 15/07/2026 2

Mutations let JC polyomavirus evade antibodies, offering clues for vaccines and treatments

In people with severely compromised immune systems, JC polyomavirus can trigger an untreatable, often fatal brain disease. An international research team has identified how virus mutations can strategically interfere with how human antibodies recognize the virus, allowing it to e

Admin Recifes 15/07/2026 2

More than 1.15 million fertility treatment cycles in Europe in 2023 as impact of frozen em

More than 1.15 million assisted reproductive technology (ART) treatment cycles were reported across Europe in 2023, according to preliminary data presented by the European IVF Monitoring (EIM) Consortium at the 42nd Annual Meeting of the European Society of Human Reproduction and

Admin Recifes 15/07/2026 2

Halving fertility treatment costs could more than double births, major global study shows

A landmark international study has found that halving patient out-of-pocket costs was associated with a 2.67-fold increase in births achieved through assisted reproductive technology (ART).

Admin Recifes 15/07/2026 2

Jolted by Ebola, countries try again to finish pandemic treaty

WHO member states kicked off one more attempt at finalizing the missing piece of the pandemic treaty on Monday, with the Ebola outbreak injecting a fresh sense of urgency.

Admin Recifes 15/07/2026 2

Gambling addiction treatment underused in Quebec, study finds

A new study finds public specialized gambling addiction treatment services are underused in Quebec, pointing to a need to better reach people with a gambling disorder. Researchers at McGill University and the Douglas Research Center followed more than 2,300 people with a gambling

Admin Recifes 15/07/2026 2

New study reveals how same day care can ease NHS emergency pressures

A new study led by the University of Sheffield and published in BMJ Open has found that up to one-third of A&E attendances and two-fifths of acute admissions could potentially be managed through same-day emergency care (SDEC) and community settings—keeping patients safe and treat

Admin Recifes 15/07/2026 2

FDA approves first treatment for thyroid eye disease

The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.

Admin Recifes 15/07/2026 2

Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time

A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune cells to help tumors survive. Researchers say the findings, published in Biofabrication, reveal possible new targets to weaken the cancer's defenses and make

Admin Recifes 15/07/2026 2

Researchers discover potential new treatment for Parkinson's disease, other neurodegenerat

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes